Abnormal Cervical Cells Requiring Cauterization (or Other Treatment)
CIN 2-3 (high-grade squamous intraepithelial lesions/HSIL) confirmed on colposcopy-directed biopsy requires treatment with either excisional procedures (LEEP, cold-knife conization) or ablative procedures (cryotherapy, laser ablation) in most women, with important age-based and pregnancy-related exceptions. 1
Which Lesions Require Treatment
Definitive Treatment Indications:
CIN 3 in all women aged 21-24 years and older:
- Must be treated with diagnostic excisional procedure (LEEP or cold-knife conization preferred)
- Hysterectomy is NOT primary treatment
- Ablation alone is unacceptable for unsatisfactory colposcopy 1
CIN 2 in women ≥25 years:
- Both excision and ablation are acceptable treatment modalities when colposcopy is satisfactory
- Diagnostic excisional procedure required if colposcopy is unsatisfactory
- Observation is unacceptable except in special circumstances 2
Age-Specific Conservative Management:
Women aged 21-24 years with CIN 2:
- Observation is recommended (not immediate treatment)
- This represents a shift toward conservative management due to high regression rates in young women
- Close surveillance with colposcopy and cytology every 6 months 1
CIN 1 at any age:
- Should NOT be treated unless persistent for 2 years
- Observation is standard management 1
Treatment Modalities
Excisional Procedures (Preferred for Diagnosis + Treatment):
- Loop Electrosurgical Excision Procedure (LEEP): Most common, provides specimen for pathology
- Cold-knife conization (CKC): Preferred when maintaining specimen integrity is critical
- Total hysterectomy: Only acceptable for CIN 3 with other gynecologic indications (e.g., symptomatic fibroids) 1, 3
Ablative Procedures (Treatment Only):
- Cryotherapy (cauterization/freezing)
- Laser ablation
- Only acceptable when:
- Colposcopy is satisfactory (entire transformation zone visualized)
- No suspicion of invasion
- Endocervical curettage is negative
- CIN 2-3 confirmed on biopsy 1
Critical Exclusions from Treatment
Pregnancy:
- Treatment of any grade CIN is NOT recommended during pregnancy
- Colposcopy and biopsy only if high-grade neoplasia or cancer suspected
- Excisional procedures only if invasion suspected and would alter management
- Endocervical curettage is unacceptable
- Postpartum re-evaluation at 6+ weeks 1, 4
Young Women (21-24 years):
- HSIL on cytology requires colposcopy but NOT immediate treatment
- Even with CIN 2 on biopsy, observation is preferred
- Only CIN 3 requires treatment in this age group 1
Post-Treatment Surveillance
After treatment for CIN 2-3:
- HPV DNA testing at 6-12 months (preferred), OR
- Cytology at 6 months
- If negative: continue routine screening for at least 20 years
- If positive margins on excision: repeat cytology at 4-6 months with endocervical sampling, or consider repeat excision 2
Common Pitfalls to Avoid
Over-treating young women (21-24 years): CIN 2 regresses frequently; observation is now standard 1
Using ablation with unsatisfactory colposcopy: Cannot visualize entire lesion = excision required 1, 2
Treating during pregnancy: Defer unless invasion suspected 4, 5
Inadequate follow-up after incomplete excision: Recent evidence suggests close surveillance may be acceptable in reproductive-age women rather than immediate re-excision, particularly when HPV-negative 6
Assuming negative margins = cure: Particularly with adenocarcinoma in situ, skip lesions and multifocal disease can persist despite negative margins 2
Risk Stratification
Immediate colposcopy required for:
- HSIL on cytology (69% risk of histologic HSIL/cancer)
- HPV+/HSIL (71% risk)
- ASC-H (35-45% risk depending on HPV status)
- Any squamous cell carcinoma on cytology 1
The term "cauterization" in clinical practice typically refers to cryotherapy (freezing) or laser ablation, both acceptable ablative treatments for confirmed CIN 2-3 when strict criteria are met, though excisional procedures are increasingly preferred as they provide tissue for pathologic confirmation and margin assessment.